Clinical Trials Logo

Filter by:
NCT ID: NCT00920179 Enrolling by invitation - Clinical trials for Primary Sjogren's Syndrome

Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome

Start date: October 2007
Phase: N/A
Study type: Observational

Traditional methodological clinical and instrumental diagnostics of the lacrimal gland for the study of glandular architecture and functions are limited and include analysis of tear constituents, evaluation of apparent diffusion coefficients in magnetic resonance imaging and histopathological evaluation of lacrimal gland biopsy specimens. Confocal microscopy is a new emerging technology which is useful as a supplementary diagnostic tool for in vivo assessment of anterior-segment disorders.The use of in vivo confocal microscopy in a comparative study of the microscopic morphology of the salivary/lacrimal glands have not been reported up to date. In this study, we employ laser scanning confocal microscopy to evaluate the morphological changes of the salivary/lacrimal glands in patients with primary Sjögren's syndrome and compare the results with those of healthy control subjects.

NCT ID: NCT00920101 Recruiting - Inflammation Clinical Trials

Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether HMG-CoA reductase inhibitor, atorvastatin attenuates inflammation in atherosclerotic plaques detected by 18F-fluorodeoxyglucose(FDG) PET.

NCT ID: NCT00919737 Completed - Malignant Glioma Clinical Trials

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Start date: June 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether NPC-08 is safety and efficacy in the treatment of newly-diagnosed malignant glioma and recurrent glioblastoma multiforme.

NCT ID: NCT00919490 Completed - HCV Infections Clinical Trials

A Study of Single Dose of ABT-333 in Healthy Male Adults

Start date: June 2009
Phase: Phase 1
Study type: Interventional

The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male adult in Japan.

NCT ID: NCT00919477 Completed - Prostate Cancer Clinical Trials

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg

CAMON
Start date: May 2009
Phase: N/A
Study type: Observational

To gather information on the safety of monotherapy of Casodex® tablets 80 mg, targeting prostate cancer patients who have no history of having received treatment by either endocrine therapy (including surgical castration).

NCT ID: NCT00918827 Completed - Colorectal Cancer Clinical Trials

Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and Chemotherapy

Start date: April 1, 2009
Phase: N/A
Study type: Observational

RATIONALE: Studying samples of tumor tissue in the laboratory from patients with cancer who have undergone surgery and chemotherapy may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is looking at tumor samples from patients with stage III colon cancer who have undergone surgery and chemotherapy.

NCT ID: NCT00918411 Completed - Clinical trials for Irritable Bowel Syndrome

A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to explore and examine endpoints that allow evaluation of the "clinically significant improvements, focusing on the patient's chief complaint and the severity of major IBS symptoms" by this drug in patients with diarrhea-predominant irritable bowel syndrome (IBS).

NCT ID: NCT00917267 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

Start date: July 2009
Phase: Phase 3
Study type: Interventional

Previous studies have suggested that a once-weekly formulation of exenatide may provide sustained glycemic control. These previous studies of exenatide once weekly have been conducted in non-Asian populations, so this study has been developed to support the local regulatory requirements of China, Korea, Japan, India, and Taiwan.

NCT ID: NCT00917254 Completed - Clinical trials for Venous Thromboembolism

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

Start date: May 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to examine the superiority of YM150 to the placebo and to evaluate the dose-dependent response of YM150 in patients undergoing elective total knee replacement surgery.

NCT ID: NCT00917150 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Start date: March 2009
Phase: Phase 2
Study type: Interventional

To investigate the efficacy and safety of OPC-6535 in COPD patients, using the measurement of trough FEV1 over time as the primary endpoint.